These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 17476650)

  • 21. Gatekeeping strategies for clinical trials that do not require all primary effects to be significant.
    Dmitrienko A; Offen WW; Westfall PH
    Stat Med; 2003 Aug; 22(15):2387-400. PubMed ID: 12872297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies.
    Hommel G; Bretz F; Maurer W
    Stat Med; 2007 Sep; 26(22):4063-73. PubMed ID: 17348083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An efficient method for accommodating potentially underpowered primary endpoints.
    Li J; Mehrotra DV
    Stat Med; 2008 Nov; 27(26):5377-91. PubMed ID: 18759248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Closure procedures for monotone bi-factorial dose-response designs.
    Hellmich M; Lehmacher W
    Biometrics; 2005 Mar; 61(1):269-76. PubMed ID: 15737103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A note on testing families of hypotheses using graphical procedures.
    Maurer W; Bretz F
    Stat Med; 2014 Dec; 33(30):5340-6. PubMed ID: 25043831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing non-inferiority and superiority for two endpoints for several treatments with a control.
    Lawrence J
    Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A method to increase the power of multiple testing procedures through sample splitting.
    Rubin D; Dudoit S; van der Laan M
    Stat Appl Genet Mol Biol; 2006; 5():Article19. PubMed ID: 17049030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some controversial multiple testing problems in regulatory applications.
    Hung HM; Wang SJ
    J Biopharm Stat; 2009; 19(1):1-11; discussion 12-41. PubMed ID: 19127460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate.
    Lehmacher W; Wassmer G; Reitmeir P
    Biometrics; 1991 Jun; 47(2):511-21. PubMed ID: 1912258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical tests based on new composite hypotheses in clinical trials reflecting the relative clinical importance of multiple endpoints quantitatively.
    Nishikawa M; Tango T; Ohtaki M
    Biom J; 2009 Oct; 51(5):749-62. PubMed ID: 19777463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A recycling framework for the construction of Bonferroni-based multiple tests.
    Burman CF; Sonesson C; Guilbaud O
    Stat Med; 2009 Feb; 28(5):739-61. PubMed ID: 19142850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A generalized Sidak-Holm procedure and control of generalized error rates under independence.
    Guo W; Romano J
    Stat Appl Genet Mol Biol; 2007; 6():Article3. PubMed ID: 17402918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interpretation of research data: hypothesis testing.
    Stolar MH
    Am J Hosp Pharm; 1980 Nov; 37(11):1539-45. PubMed ID: 7211860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the power of some binomial modifications of the Bonferroni multiple test.
    Teriokhin AT; de Meeûs T; Guégan JF
    Zh Obshch Biol; 2007; 68(5):332-40. PubMed ID: 18038646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring pairwise comparisons in multi-armed clinical trials.
    Follmann DA; Proschan MA; Geller NL
    Biometrics; 1994 Jun; 50(2):325-36. PubMed ID: 8068834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of multiple intersection-union tests for multiple endpoints in combination therapy trials.
    Westfall PH; Ho SY; Prillaman BA
    J Biopharm Stat; 2001; 11(3):125-38. PubMed ID: 11725927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.